Clinical Trials on Moderately Active Ulcerative Colitis

Total 1805 results

Hoffmann-La Roche

Recruiting

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis (AMETRINE-PEDS)

Moderately to Severely Active Ulcerative Colitis

United States, Taiwan, Australia, Canada, Thailand, United Kingdom, South Africa, China, Brazil
Nanjing Immunophage Biotech Co., Ltd
Peking Union Medical College

Not yet recruiting

Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)

Moderately to Severely Active Ulcerative Colitis (UC)

China
Shandong Suncadia Medicine Co., Ltd.

Recruiting

A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

Adult Patients With Moderately to Severely Active Ulcerative Colitis

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Active, not recruiting

A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis

Adult Patients With Moderately to Severely Active Ulcerative Colitis

China
Eli Lilly and Company

Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis (EMERALD-3)

Ulcerative Colitis, Active Severe | Ulcerative Colitis (UC) | Ulcerative Colitis, Active Moderate

Israel, United States, Japan, China, Croatia, India, Hungary, Taiwan, Brazil, France, Poland, Greece, Czechia, Italy, Argentina, Serbia, Colombia, Lithuania, Latvia, Puerto Rico, Ukraine, Slovakia, South Africa, Portugal, Mexico, Canada, Turkey... and more

Clinical Trials on Moderately Active Ulcerative Colitis

This is a preview